APACC
Meeting category
Date(s)
17 May 2016 - 19 May 2016
Location
Hong Kong, Hong Kong
Organizer
Titanium Level Support
Sponsor logos
ViiW

APACC 2016

Related Enduring Materials

Enduring Materials
Opening Session -
Honorary lecture: Future Challenges in treatment optimization for Asia
David Cooper, MD, DSc
University of New South Wales; Australian Academy of Science, Australia
Towards an HIV Cure; understanding the major barriers
Sharon Lewin, AO, FRACP, PhD, FAHMS
Peter Doherty Institute for Infection and Immunity, Australia
Towards an HIV Cure; clinical strategies and trials
Jintanat Ananworanich, MD, PhD
US Military HIV Research Program, United States
HIV Drug Resistance -
HIV Drug Resistance
Shinichi Oka, MD, PhD
National Center for Global Health and Medicine, Japan
An overview of drug resistance mutations in HIV-1 pol gene (Hong Kong, 1994 ā€“ 2013)
placeholder3
Dr. S. To
-
Transmitted drug resistance mutations among antiretroviral-naƏve adult patients in northern Vietnam
placeholder3
Vu Phuong Thao, PhD
Oxford University Clinical Research Unit Ho Chin Minh City, Viet Nam
The impact of NRTI resistance on the public health approach to PI-based second-line therapy in resource limited settings
Thuy Le, MD, DPhil
Duke University; Oxford University Clinical Research Unit, United States / Vietnam
Next Generation Sequencing for Detection of Drug Resistance Mutations in HIV-1
placeholder3
Dr. Rakhmanaliev
-
Perinatal, pediatric, and adolescent HIV priorities -
Elimination of perinatal HIV: the Role of Safer Conception Strategies
Shannon Weber
Shannon Weber, MSW
HIVE, USA
They are not kids anymore: Standing at the crossroads of adolescent HIV Care
Annette Sohn, MD, PhD
TREAT Asia/amfAR, Thailand
Psychosocial Determinants of Anxiety and Depression among Children of HIV-infected Parents: a 3-year Longitudinal Study in Mainland China
placeholder3
Meiqi Xin
The Chinese University of Hong Kong
Opportunistic Infections -
Advances in the treatment of Cryptococcal Meningitis
Jeremy Day
Jeremy Day, PhD FRCP
Hopsital for Tropical Diseases, Viet Nam
TB Clinical Management Challenges
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
Concurrent outbreaks of hepatitis A and shigellosis among HIV-infected MSM in Taiwan, 2015-2016: the emerging threat of enteric coinfections
Philip Yi-Chun Lo, MD
Taiwan CDC, Taiwan
The Patterns of Primary Cotrimoxazole Prophylaxis in Adult HIV Patients in HIV Integrated Clinic Cipto Mangunkusumo Hospital Jakarta in 2004-2013
placeholder3
Ken Ayu Mastini
University of Indonesia, Indonesia
Epidemiology / HIV Transmission -
HIV surveillance ā€“ Are we missing out on key populations?
Transmission networks among MSM
Shui-Shan Lee, MD, FRCP, FRCPA, FFPH
The Chinese University of Hong Kong, China
Prevention -
Integrating PrEP in prevention
Robert Grant
Robert Grant, MD, MPH
University of California, San Francisco, USA
Long-term Comorbidities -
Long-term comorbidities
Saye Khoo, MD, PhD
Royal Liverpool University Hospital; University of Liverpool, United Kingdom
Clinical case presentation
Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP
Queen Elizabeth Hospital, Hong Kong
Hyperlipidaemia and its association with CD4 recovery following antiretroviral therapy
placeholder3
Denise Chan
The Chinese University of Hong Kong
HIV Associated Osteoporosis in Singapore: Prevalence and Risk Factors
placeholder3
Dr. N. Chew
-
Metabolic Syndrome among Malaysian HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort
placeholder3
Sivaraj Naidu, MMedSc
University of Malaya, Malaysia
"Aspartate Aminotransferase to Platelet Ratio Index (APRI) is a Simple Test for Diagnosis Liver Cirrhosis in HIV Patients"
placeholder3
Dr. K. Mariad
-
Hepatitis HIV Co-infection -
Clinical case presentation
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1
Dr. J. Rockstroh
-
Liver Fibrosis and Fatty Liver in Asian HIV-monoinfected Patients
Dr. C. Lui
-
Modelling treatment scale-up in Australia to achieve global hepatitis C virus incidence and mortality elimination targets
Dr. J. Doyle
-
Eliminating hepatitis C transmission by enhancing care and treatment among HIV co-infected individuals: The co-EC Study
Dr. J. Doyle
-
HIV Vaccine Research -
Development of HIV Vaccine Candidates for Prevention and Treatment
Sandhya Vasan
Sandhya Vasan, MD
Armed Forces Research Institute of Medical Sciences/ US Military HIV Research Program, Thailand
Immune responses among participants with additional boosting of ALVAC/AIDSVAX vaccines after receving the RV 144 regimen (RV 305 & RV 306 studies)
Punnee Pitisuttithum
Punnee Pitisuttithum, MD, DTMH
Mahidol University, Thailand
HIV prevention and cure using a potent bi-specific bnAb
placeholder3
Dr. Z. Chen
-
Using the HVTN model to conduct HIV vaccine clinical trials
Xia Jin
Xia Jin, MD, PhD
Ramathibodi Hospital, Mahidol University, Thailand
Clinical Management -
Sensitive Detection of Tenofovir-induced Tubular Injury with Urinary Ɵ-2 Microglobuline in Vietnam
Daisuke Mizushima
Daisuke Mizushima
National Center for Global Health and Medicine
Tenofovir-induced kidney tubular dysfunction in HIV-infected patients in Hong Kong
Denise Chan
The Chinese University of Hong Kong
Safety and efficacy of tenofovir disoproxil fumarate plus emtricitabine for HIV pre-exposure prophylaxis in Thailand
Donn Colby, MD, MPH
U.S. Military HIV Research Program (MHRP) / Center for Applied Research on Men and Community Health, United States / Vietnam
Treat-all strategy decreased HIV infection but increased syphilis in a community - based MSM cohort in Ulaanbaatar in 2015
placeholder3
Dr. M. Takano
-
Test and Treat strategy has high potential to reduce HIV and syphilis infections in a prison setting
placeholder3
Dr. T. Suthikiri
-
HIV Testing & Counseling and Prevention Interventions in High Risk Populations -
High rate of HIV seroconversion among long-term repeat HIV testers at the Thai Red Cross Anonymous Clinic
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
A randomized controlled trial promoting HIV self-testing with online real-time counseling on increasing HIV testing rate among MSM in Hong Kong
Dr. Z. Wang
-
Go Viral On-line: Social Media Strategy in HIV Testing Behaviour in Hong Kong
Dr. N. Kwan
-
A randomized controlled trial evaluating the efficacy of a brief social media intervention in reducing sexual risk behaviors among MSM in Beijing
Dr. R. She
-
Acceptability study on HIV Self-Testing among female entertainment workers, men who have sex with men, and transgender women in Cambodia: A Qualitative Analysis
Dr. K. Pal
-
Hepatitis Viruses -
Hepatitis B
Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Victorian Infectious Diseases Reference Laboratory
Hepatitis C
Ching-lung Lai, MD, FRCP, FRACP
University of Hong Kong, Hong Kong, China
Hepatitis - HIV Co-infection
JĆ¼rgen Rockstroh, MD
University of Bonn, Germany
Novel Therapeutic Approaches/Future Challenges -
Long Acting Antivirals for Treatment and Prevention
Martin Markowitz, MD
Rockefeller University, United States
Innovative Clinical Models
Nittaya Phanuphak, MD, PhD
Institute of HIV Research and Innovation in Bangkok, Thailand
Overview
Overview

We would like to thank everyone who joined us at theĀ 2016 Asia Pacific AIDS & Co Infections ConferenceĀ make this event a truly groundbreaking success. We are overwhelmed by the positive feedback and remarks!

Please join our mailing list and stay informed on next yearā€™s event, we would be delighted to reunite with you and many more at the 2017 APACC in 1-3 June 2017!

More images and presentations of APACC 2016Ā are available online.

General InformationĀ 

Unique Features
- A program with a special focus on the needs in Asia and the Pacific

- A true scientific platform for regional clinicians and clinical researchers to present their data

- Insights into important clinical developments and updates on ongoing and new trials

- Capacity building workshops and career development sessions for young professionals

- A great opportunity to network with your colleagues throughout Asia
Meeting Objectives
This meeting aims to:

- Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment

- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population

- Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice
Learning Objectives
After participating in this activity, participants will be able to:

- Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region

- Identify improved treatment options for their patients

- Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region

- Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings

Practical InformationĀ 

Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Conference Chairs 2016
Scientific Committee

The members of Scientific Committee assist the ProgramĀ Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

We are proud to present the members of the Committee:Ā 

  • Zhiwei Chen, PhD, DVM
  • Jun Yong Choi, MD, PhD
  • Rino A Gani, MD, PhD (Indonesia)
  • Ishwar Gilada, MD, DDV, FCPS
  • Yee-Tak Hui, FHKAM, FRCP
  • Chien-Ching Hung, MD, PhD (Taiwan)
  • Aikichi Iwamoto, MD, DMSci (Japan)
  • Adeeba Kamarulzaman, MBBS, FRACP
  • Thana Khawcharoenporn, MD, MSc
  • Saye Khoo, MD, PhD
  • N. Kumarasamy, MD, PhD
  • Eternity Labio, MD (Philippines)
  • Nguyen Lan Anh Thi, MD, PhD (Vietnam)
  • Thuy Le, MD, DPhil
  • Christopher Lee, MBBS, MRCP, FRCP (Malaysia)
  • Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP
  • Nelson Lee, MBBS, MD, FRCP, FHKCP, FHKAM (Hong Kong)
  • Seng Gee Lim, MBBS, FRACP, FRCP, MD
  • Hsi-Hsun Lin, MD, PhD
  • Hongzhou Lu, MD, PhD
  • Tuti Parwati Merati, MD, PhD (Indonesia)
  • Shinichi Oka, MD, PhD
  • Kiat Ruxrungtham, MD
  • Yiming Shao, MD, PhD
  • Thomas Man-Kit So (Hong Kong)
  • Somnuek Sungkanuparph, MD (Thailand)
  • Akifumi Takaori-Kondo, MD, PhD
  • Tawesak Tanwandee, MD (Thailand)
  • Owen Tsang, MBChB, MRCP, FHKCP, FHKAM, MTH, DTM&H, MSc, LSHTM, FRCP
  • Nguyen Van Kinh, MD, PhD (Vietnam)
  • Rudi Wisaksana, MD, PhD
  • Evy Yunihastuti, MD, PhD
  • Hui Zhuang, MD
Support
Endorsers
Language